Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity.
暂无分享,去创建一个
T. Horii | T. Yasui | H. Kikutani | T. Kishimoto | K. Yoshida | M. Kamanaka | T. Kawabe | P. Yu | T. Horii
[1] D. Gray,et al. CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.
[2] R. Flavell,et al. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.
[3] I. Charles,et al. Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.
[4] J. Gribben,et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. , 1995, Immunity.
[5] C. Maliszewski,et al. Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction , 1995, European journal of immunology.
[6] Laurie H Glimcher,et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.
[7] D. Lawrence,et al. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1 , 1995, European journal of immunology.
[8] F. Alt,et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Suttles,et al. Role of the CD40‐CD40 ligand interaction in CD4+ T cell contact‐dependent activation of monocyte interleukin‐1 synthesis , 1994, European journal of immunology.
[10] R J Armitage,et al. Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.
[11] J. Banchereau,et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells , 1994, The Journal of experimental medicine.
[12] A. Aruffo,et al. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. , 1994, The Journal of clinical investigation.
[13] R. Flavell,et al. Mice deficient for the CD40 ligand. , 1994, Immunity.
[14] P. Linsley,et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. , 1994, Journal of immunology.
[15] N. Yoshida,et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. , 1994, Immunity.
[16] G. Trinchieri,et al. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones , 1994, The Journal of experimental medicine.
[17] R. Locksley,et al. CD4+ effector cells default to the Th2 pathway in interferon gamma- deficient mice infected with Leishmania major , 1994, The Journal of experimental medicine.
[18] L. Lanier,et al. B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.
[19] A. Sher,et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Aruffo,et al. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. , 1993, Science.
[21] M. Gately,et al. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. , 1993, Journal of immunology.
[22] W. Fanslow,et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.
[23] G. Starling,et al. B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation. , 1993, Immunology.
[24] D. Wirth,et al. Transfected Leishmania expressing biologically active IFN-gamma. , 1993, Journal of immunology.
[25] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[26] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[27] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[28] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[29] J. Belmont,et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome , 1993, Science.
[30] L. Notarangelo,et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM , 1993, Nature.
[31] A. Fischer,et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.
[32] J. Bajorath,et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.
[33] R. Coffman,et al. Reconstitution of C.B‐17 scid mice with BALB/c T cells initiates a T helper type‐1 response and renders them capable of healing Leishmania major infection , 1993, European journal of immunology.
[34] P. Casellas,et al. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. , 1992, The Journal of biological chemistry.
[35] G. Freeman,et al. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. , 1991, Cellular immunology.
[36] R. Locksley,et al. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. , 1991, Journal of immunology.
[37] R. Locksley,et al. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Abbas,et al. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution , 1990, Infection and immunity.
[39] S. Moncada,et al. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. , 1990, Journal of immunology.
[40] R. Locksley,et al. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism , 1990, The Journal of experimental medicine.
[41] M. Belosevic,et al. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. , 1989, Journal of immunology.
[42] G. Freeman,et al. Isolated human follicular dendritic cells display a unique antigenic phenotype , 1989, The Journal of experimental medicine.
[43] R. Locksley,et al. Powered by the California Digital Library University of California RECIPROCAL EXPRESSION OF INTERFERON y OR INTERLEUKIN 4 DURING THE RESOLUTION OR PROGRESSION OF MURINE LEISHMANIASIS Evidence for Expansion of Distinct Helper T Cell Subsets , 2003 .
[44] J. McKenzie,et al. Isolation and characterization of human tonsil dendritic cells , 1988, The Journal of experimental medicine.
[45] T. Boon,et al. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.
[46] C. Taswell,et al. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.
[47] R. Locksley,et al. The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.
[48] J. Banchereau,et al. The CD40 antigen and its ligand. , 1994, Annual review of immunology.
[49] F. Liew,et al. Immunology of leishmaniasis. , 1993, Advances in parasitology.
[50] L. Notarangelo,et al. Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.
[51] J. Louis,et al. T-cell responses and immunity to experimental infection with leishmania major. , 1989, Annual review of immunology.